ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: Gritz Heads New Dept. At M.D. Anderson; NCI Grants Manager Leo Buscher honored

July 16, 1993

FIT More Effective Than gFOBT In All Colonoscopy Capacities

November 25, 2011

PLCO Data Confirm Importance Of Regular Colorectal Cancer Screening, NCI Says

July 25, 2003

In Brief: NCAB Committee Worried About Requirements for Comprehensive Centers, To Meet Again

May 27, 1988

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

Clinical Trials: Oncologists, Insurance Executive, Comment On The Results Of Transplant Trials

May 28, 1999